Director, US Analytics, Lung

Role: Lead analytics for Revolution Medicines’ lung cancer portfolio, focusing on generating insights to inform strategic decisions, launch planning, and commercialization efforts. Responsibilities: partner with cross-functional teams (Commercial, Medical Affairs, Market Access, Clinical), analyze patient, physician, claims, EMR, and market data; develop segmentation, market opportunity assessments, and competitive landscape evaluations; monitor treatment standards, and support data strategy and vendor management. Requirements: Bachelor’s degree; 8+ years in healthcare analytics, preferably oncology, with experience in claims, EMR, specialty pharmacy, and product launch support; strong analytical, strategic, and communication skills; proven stakeholder influence. Preferred: advanced degrees (MBA, MPH, MS, PhD), deep NSCLC and biomarker-driven oncology expertise, experience with predictive modeling, AI/ML, and working in growth-stage biotechs. HighValue: oncology (lung cancer), biomarker-driven markets, pre- or post-launch analytics, healthcare datasets, strategic insights, cross-functional collaboration. WorkSetup: based in Redwood City, CA, with flexibility for remote candidates and regular travel.